Related Experiment Videos
Induced expression of alpha-enolase in differentiated diffuse large cell lymphoma
R M Mohammad1, M Y Hamdan, A al-Katib
1Department of Internal Medicine, Wayne State University, Detroit, Mich., USA.
Enzyme & Protein
|January 1, 1994
Summary
Researchers discovered alpha-enolase, a protein linked to cell differentiation, in human diffuse large cell lymphoma (DLCL) cells treated with Bryostatin 1. This finding suggests alpha-enolase may be crucial in lymphoma development.
Area of Science:
- Oncology
- Biochemistry
- Cell Biology
Background:
- Diffuse large cell lymphoma (DLCL) is a significant hematologic malignancy.
- Understanding the molecular mechanisms of DLCL differentiation is crucial for developing targeted therapies.
Purpose of the Study:
- To identify unique proteins associated with the differentiation of human DLCL cells.
- To investigate the effect of Bryostatin 1 (Bryo1) on protein expression in WSU-DLCL cells.
Main Methods:
- Culturing WSU-DLCL cells with and without Bryostatin 1.
- Analyzing cellular proteins using one-dimensional (1D) and two-dimensional (2D) polyacrylamide gel electrophoresis (PAGE).
- Partial amino acid sequencing of identified protein spots.
Main Results:
- A unique protein band (~47 kD) was observed in differentiated DLCL cells but not in parent cells.
- 2D PAGE identified a protein with an isoelectric point of 7.4.
- Partial sequencing revealed 100% homology with alpha-enolase, a glycolytic enzyme.
Conclusions:
- This study reports the first instance of alpha-enolase induction in human DLCL following Bryostatin 1 treatment.
- Alpha-enolase is suggested to play a significant role in human lymphoma differentiation.